QUIDEL MOLECULAR DIRECT HSV 1 +2/VZV ASSAY

Herpes Virus (vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples

DIAGNOSTIC HYBRIDS, INC.

The following data is part of a De Novo classification by Diagnostic Hybrids, Inc. with the FDA for Quidel Molecular Direct Hsv 1 +2/vzv Assay.

Pre-market Notification Details

DeNovo IDDEN140004
Device Name:QUIDEL MOLECULAR DIRECT HSV 1 +2/VZV ASSAY
ClassificationHerpes Virus (vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples
Applicant DIAGNOSTIC HYBRIDS, INC. 2005 E State St Ste 100 Athens,  OH  45701
ContactRonald H Lollar
Product CodePGI  
CFR Regulation Number866.3309 [🔎]
DecisionGranted (DENG)
510(k) Premarket NotificationK133448
Review Advisory BoardMicrobiology
Classification AdvisoryMicrobiology
TypePost-NSE
Date Received2014-02-21
Decision Date2014-05-13
FDA ReviewDecision Summary
Reclassification Order:Reclassification Order

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
30014613311027 DEN140004 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.